BI1744CL

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI1744CL, covering 2015-08-13 to 2015-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD) [Phase 2]

See pricing